Drug
Saproterin Dihydrochloride
Saproterin Dihydrochloride: highest development phase Post-Market, developed by BioMarin Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| saproterin dihydrochloride NCT02677870 | Post-Market | Phenylketonuria |
Latest
No recent events.
Follow Saproterin Dihydrochloride on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.